Article Text
Statistics from Altmetric.com
Q In vulnerable patients with poorly controlled type 2 diabetes mellitus, does a pharmacist led, primary care-based, disease management programme reduce cardiovascular risk factors and improve glycaemic control?
Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ Internal medicine ★★★★★★☆ Cardiology ★★★★★★☆ Endocrine ★★★★★★☆
METHODS
Design:
randomised controlled trial.
Allocation:
{concealed*}†.
Blinding:
blinded (outcome assessors {and data collectors}†).
Follow up period:
1 year.
Setting:
University of North Carolina General Internal Medicine Practice, Chapel Hill, North Carolina, USA.
Patients:
217 English speaking patients who were ⩾18 years of age, had a clinical diagnosis of type 2 …
Footnotes
-
↵† Information provided by author.
-
For correspondence: Dr R Rothman, Vanderbilt University Medical Center, Nashville, TN, USA. russell.rothmanvanderbi
-
Sources of funding: Robert Wood Johnson Clinical Scholars Program, University of North Carolina, and Vanderbilt Center for Health Services Research.
Linked Articles
- Glossary